Make your money go further for just 25p per day

AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

31/07/2020 · AstraZeneca (AZN)  · GlaxoSmithKline (GSK)  · Tristel (TSTL) 

Coronavirus Pharma and Biotech UK

GSK logo

The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes of investors – could really benefit from the period of immense disruption.


But financial results from the UK’s two pharma giants reveal that there is another trend in play here: focus on Covid-19 has dented demand for other, less pressing treatments. Routine GP appointments, prescriptions and subsequently pharma sales have declined in the last three months.

That was reflected in half year results at GlaxoSmithKline (LON: GSK) where an 8% like-for-like decline in sales to £7.6bn came in behind analyst estimates. Falling demand was experienced across all three…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on AstraZeneca

AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

31/07/2020 · Company Insights

The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…


Coronavirus impact: 29 April - surging profits and depression era declines

29/04/2020 · Company Insights

One of the world’s largest companies issued impressive results but the outlook is significantly more challenging.…


More on GlaxoSmithKline

Mega-Trends Portfolio: CRISPR is the future

17/03/2021 · Portfolio

We have covered CRISPR/Cas9 before and hailed it as one of the most important inventions of…


CRISPR: one of the most important inventions of the century?

15/01/2021 · Portfolio

CRISPR is up there with electricity and fire. It stands for clustered regulated interspaced short palindromic…


More on Tristel

Music to our ears

27/04/2021 · Company Insights

One of our AIM favourites covered here announced fabulous results, delivering huge growth in revenue and profits.…


Strong results to start the week

22/02/2021 · Company Insights

There were strong results to start the week from a provider of mobile payment services and…


More Company Insights

Agronomics: illustrates the crazy nature of the market

13/05/2021 · Agronomics

Bonkers Bargains: Where there’s muck…

13/05/2021